Private Capital Management (Florida)’s Ligand Pharmaceuticals LGND Stock Holding History

Private Capital Management (Florida)’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$40.2M	Sell	201,381 -7,510	-4%	-$1.49M	4%	7
2025 Q4	$39.5M	Sell	208,891 -18,267	-8%	-$3.51M	3.62%	5
2025 Q3	$40.2M	Sell	227,158 -2,095	-0.9%	-$311K	3.59%	5
2025 Q2	$26.1M	Buy	229,253 +81,128	+55%	+$8.67M	2.52%	16
2025 Q1	$15.5M	Buy	148,125 +14,435	+11%	+$1.63M	1.7%	22
2024 Q4	$14.3M	Sell	133,690 -190	-0.1%	-$21.5K	1.5%	24
2024 Q3	$13.4M	Sell	133,880 -625	-0.5%	-$62.9K	1.44%	23
2024 Q2	$11.3M	Buy	+134,505	New	+$10.7M	1.32%	25

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

Private Capital Management (Florida)'s LGND Position: Q1 2026 in Review

Private Capital Management (Florida) reduced its Ligand Pharmaceuticals (LGND) stake by 3.6% in Q1 2026, selling an estimated $1.49M and leaving 201,381 shares worth $40.2M. The position accounts for 4% of the portfolio, ranked #7.

Private Capital Management (Florida) first reported a position in LGND in Q2 2024 and has held it in 8 quarters since. The position peaked at $40.2M in Q3 2025. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

Private Capital Management (Florida) held 201,381 shares of Ligand Pharmaceuticals worth $40.2M as of Q1 2026.
Private Capital Management (Florida) sold 7,510 Ligand Pharmaceuticals shares in Q1 2026, an estimated $1.49M.
Ligand Pharmaceuticals made up 4% of Private Capital Management (Florida)'s portfolio in Q1 2026, its #7 holding.
Private Capital Management (Florida) first reported a position in Ligand Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
Private Capital Management (Florida)'s Ligand Pharmaceuticals position peaked at $40.2M in Q3 2025.
357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on Private Capital Management (Florida)'s 13F filing for Q1 2026, filed 15 May 2026.